LifeMine Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 51

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $188M

  • Investors
  • 20

LifeMine General Information

Description

Developer of a drug discovery platform designed to elucidate human biology and create sophisticated therapeutics that attack the fundamental drivers of serious human diseases. The company's platform offers mining of fungal biodiversity to develop mechanistically and structurally novel therapeutics to address previously intractable therapeutic challenges, enabling healthcare providers to treat intractable human diseases via biological mechanisms.

Contact Information

Formerly Known As
LifeMine Biotherapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Cambridge Discovery Park
  • 30 Acorn Park Drive
  • Cambridge, MA 02140
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Cambridge Discovery Park
  • 30 Acorn Park Drive
  • Cambridge, MA 02140
  • United States
+1 (617)

LifeMine Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LifeMine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 06-Aug-2026 $188M Completed Generating Revenue
5. Secondary Transaction - Private 01-Feb-2026 Completed Generating Revenue
4. Later Stage VC (Series D) 25-Sep-2025 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Mar-2022 Completed Generating Revenue
2. Later Stage VC (Series B) 07-Jan-2021 $50M $125M Completed Startup
1. Early Stage VC (Series A) 15-Sep-2017 $75.1M $75.1M Completed Startup
To view LifeMine’s complete valuation and funding history, request access »

LifeMine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B
Series A2 38,862,045 $0.000100 $0.93 $0.93 1x $0.72 5.61%
Series A1 47,836,085 $0.000100 $0.76 $0.76 1x $0.61 6.56%
To view LifeMine’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

LifeMine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to elucidate human biology and create sophisticated therapeutics that at
Drug Discovery
Cambridge, MA
51 As of 2025

Copenhagen, Denmark
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LifeMine Competitors (42)

One of LifeMine’s 42 competitors is Snipr Biome, a Venture Capital-Backed company based in Copenhagen, Denmark.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Snipr Biome Venture Capital-Backed Copenhagen, Denmark
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
Enterome Venture Capital-Backed Paris, France
Eligo Bioscience Venture Capital-Backed Paris, France
4D pharma Corporation Leeds, United Kingdom
You’re viewing 5 of 42 competitors. Get the full list »

LifeMine Patents

LifeMine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026188020-A1 Polymorphs of a triester compound and methods of use thereof Pending 06-Mar-2025
WO-2026188020-A9 Polymorphs of a triester compound and methods of use thereof Pending 06-Mar-2025
US-20260176304-A1 Novel cyclodepsipeptides and cyclopeptides and their use in therapy Pending 21-Nov-2024
WO-2026112278-A1 Novel cyclodepsipeptides and cyclopeptides and their use in therapy Pending 21-Nov-2024
AU-2025258247-A1 Tricyclic compounds and methods of use thereof Pending 17-Apr-2024 C07D321/10
To view LifeMine’s complete patent history, request access »

LifeMine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LifeMine Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bezos Expeditions Family Office Minority
Explore Investments Venture Capital Minority
Gates Frontier Venture Capital Minority
RA Capital Management Asset Manager Minority
Lola Capital Partners Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

LifeMine FAQs

  • When was LifeMine founded?

    LifeMine was founded in 2016.

  • Where is LifeMine headquartered?

    LifeMine is headquartered in Cambridge, MA.

  • What is the size of LifeMine?

    LifeMine has 51 total employees.

  • What industry is LifeMine in?

    LifeMine’s primary industry is Drug Discovery.

  • Is LifeMine a private or public company?

    LifeMine is a Private company.

  • What is the current valuation of LifeMine?

    The current valuation of LifeMine is .

  • What is LifeMine’s current revenue?

    The current revenue for LifeMine is .

  • How much funding has LifeMine raised over time?

    LifeMine has raised $563M.

  • Who are LifeMine’s investors?

    Bezos Expeditions, Explore Investments, Gates Frontier, RA Capital Management, and Lola Capital Partners are 5 of 20 investors who have invested in LifeMine.

  • Who are LifeMine’s competitors?

    Snipr Biome, Vedanta Biosciences, Enterome, Eligo Bioscience, and 4D pharma are some of the 42 competitors of LifeMine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process